177 results
Page 5 of 9
8-K
EX-99.2
f34ac
20 Nov 13
Proposed Public Offering of Common Stock and Warrants
12:00am
424B5
xjgh5re1
19 Nov 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
4wecoqaz
16 Sep 13
Other Events
12:00am
424B5
jn3y3m4of2e
9 Aug 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
882rhf26vaeopsymhuc
9 Aug 13
Other Events
12:00am
8-K
EX-99.1
lcdqng2
23 May 13
Other Events
12:00am
8-K
EX-99.1
90f2hheb1yahlx0
3 May 13
Interviews of NW Bio’s Ceo, on the Floor of the New York Stock Exchange, Now Available Online
12:00am
8-K
EX-99.1
jdza 4xu3i79
22 Apr 13
NW Bio Announces $10 Million Registered Direct Offering
12:00am
424B5
qf5grxiu
22 Apr 13
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
cmohloc59e5zfppf tm
22 Apr 13
NW Bio Announces $10 Million Registered Direct Offering
12:00am
8-K
EX-99.1
34d0va ad6a
8 Apr 13
NW Bio 2012 ANNUAL REPORT SHOWS STRONG PROGRESS
12:00am
8-K
EX-99.1
a6k0gyhlgr0nvc1m5i
18 Mar 13
NW Bio Receives U.S. Patent On Broad Processes For Producing More Potent Dendritic Cells
12:00am
S-3/A
dywy ed71
25 Jan 13
Shelf registration (amended)
12:00am
S-3
s0pc5e vza1
7 Jan 13
Shelf registration
12:00am
8-K
EX-99.1
25hg4k0j
17 Dec 12
Regulation FD Disclosure
12:00am
424B4
mxlp4x90ac8inmia
10 Dec 12
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
w6vbz4l nzw8vt
7 Dec 12
Northwest Biotherapeutics Announces Public Offering of Common Stock and Warrants, and Listing on NASDAQ
12:00am
8-K
EX-99.1
s1hv0
26 Sep 12
Amendments to Articles of Incorporation or Bylaws
12:00am